SAL0133

· Shenzhen Salubris Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SAL0133, covering 2025-06-22 to 2025-06-22. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Safety, Tolerability and Pharmacokinetic of SAL0133 Tablets in Chinese Adult Healthy Subjects [Phase 1]

See pricing